Executive Summary
The reset is structural
On 26 June 2025 the Ministry of Public Health made cannabis flower a "controlled herb" sold only on a doctor's prescription [MoPH 2025], banning recreational, online and advertised sales. This did not ban cannabis — it moved the plant from a near-open retail market into a traditional-medicine framework. The wide-open dispensary model that defined 2022-24 is being dismantled by design, not by accident.
Contraction, then reconstitution
The shop base is falling hard: of 8,636 licences that expired in 2025, only 1,339 renewed [DTAM 2025], and a further 9,800 expire across 2026-27. Yet a smaller, compliant market is forming underneath — anchored by prescriptions, GACP-certified supply and export flow. The next 18 months decide who survives the licensing gate.
From the green rush to the reset
Decriminalisation in June 2022 unleashed a fast, informal build-out — thousands of shops, a claimed THB 42.8 bn economy and up to 60,000 jobs [UTCC 2025]. The 2025 reset does not erase that base; it re-channels it toward medical and export value at a lower headline run-rate.
The green-rush peak
The University of the Thai Chamber of Commerce sized the cannabis and hemp economy at up to THB 42.8 bn (~USD 1.2 bn) by 2025, growing 10-15% a year, supporting as many as 60,000 jobs and drawing over THB 6 bn of investment [UTCC 2025]. Much of that value sat in unregulated retail and tourism-facing sales.
What the reset removes
The June 2025 rules strip out recreational, online and advertised sales — the fastest-growing, least-defensible slice. Our reads see the addressable pool contracting through 2026 [Kira estimates] as tourist and casual demand exits before medical and export channels scale.
What it preserves
Cannabis stays legal. The durable value — medical dispensing, GACP cultivation, extracts and exportable flower — remains, and re-rates on quality and compliance rather than on shop count.